Lexpos News

/Lexpos News

February 2024 Price Concessions 3rd Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (23/02/2024) announced the following list of price concessions for February 2024. Please note: We are still in discussion with DHSC on a number other medicines affected by pricing [...]

The post February 2024 Price Concessions 3rd Update appeared first on Community Pharmacy England.

By |February 23rd, 2024|Lexpos News|Comments Off on February 2024 Price Concessions 3rd Update

C-19 vacs: Preparing for a successful Spring 2024 vaccination campaign

NHS England has written to pharmacy teams to provide further details on the Spring 2024 COVID-19 vaccination campaign including information on timings of the campaign. The letter says that visits to vaccinate patients in older adult care homes and eligible housebound patients should begin on 15th April 2024. For all other eligible cohorts, vaccinations should [...]

The post C-19 vacs: Preparing for a successful Spring 2024 vaccination campaign appeared first on Community Pharmacy England.

By |February 22nd, 2024|Lexpos News|Comments Off on C-19 vacs: Preparing for a successful Spring 2024 vaccination campaign

Oriel – Foundation Trainee Pharmacist Recruitment Scheme 2024

NHS England have asked us to communicate the following reminder to pharmacy owners. To recruit a foundation trainee pharmacist for the 2025-26 foundation training year, employers must register with the National Recruitment Scheme (Oriel) by 1st March 2024. Please ensure you are registered in time by accessing the online form and associated information. NHS England, [...]

The post Oriel – Foundation Trainee Pharmacist Recruitment Scheme 2024 appeared first on Community Pharmacy England.

By |February 21st, 2024|hee, Lexpos News, Workforce|Comments Off on Oriel – Foundation Trainee Pharmacist Recruitment Scheme 2024

Mounjaro® (Tirzepatide) KwikPen® – availability and reimbursement

Eli Lilly and Company Ltd has recently launched Mounjaro® (tirzepatide), a new diabetes drug which is also indicated for the treatment of weight loss. Mounjaro® comes in a KwikPen® or auto-injector pre-filled injection pen containing 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg of tirzepatide. Currently, only the 2.5mg and 5mg strengths of the KwikPen® are [...]

The post Mounjaro® (Tirzepatide) KwikPen® – availability and reimbursement appeared first on Community Pharmacy England.

By |February 21st, 2024|Lexpos News|Comments Off on Mounjaro® (Tirzepatide) KwikPen® – availability and reimbursement

Medicine Supply Notification: Epilim® (sodium valproate) syrup 200mg/5ml

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Epilim® (sodium valproate) syrup 200mg/5ml MSN/2024/023 Tier 2 – medium impact Date of issue: 21st February 2024 Epilim® 200mg/5ml syrup is out of stock from mid-March until w/c 22nd April 2024. Epilim® (sodium valproate) 200mg/5ml liquid (sugar-free) remains available and can [...]

The post Medicine Supply Notification: Epilim® (sodium valproate) syrup 200mg/5ml appeared first on Community Pharmacy England.

By |February 21st, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Epilim® (sodium valproate) syrup 200mg/5ml